title: Comparison of chemotherapy education and patient preferences in community versus academic gynecology oncology clinics.
abstract: OBJECTIVE
  To evaluate and compare patients' preferences in receiving chemotherapy education from health care teams in community versus academic clinics.
  
  
  METHODS
  Results from a 13-question questionnaire about the chemotherapy education preferences of patients in three community gynecology oncology clinics were compared to the results from a similar study previously conducted in an academic gynecology oncology clinic.
  
  
  RESULTS
  A total of 57% of the 203 community-clinic respondents (116) and 67% of the 282 academic-institution respondents (189) who completed questionnaires had previously received chemotherapy. Of the patients treated in community clinics, almost 60% preferred chemotherapy education to be provided in written form and directly by a health care professional compared to 87% of the patients in academic clinics. Overall, 88% of the patients in the community clinics believed they received adequate information, compared to 63% of the patients in the academic setting. Patients in the community clinics wanted to get more in-depth answers to questions such as 'What is chemotherapy?' (54%) and 'How it is given?' (55%). In addition, community patients also wanted to know more about 'Why chemotherapy stops working?' (72%) and 'What to do and who to call about side effects?' (60%). In the academic setting, patients were less likely to want to know more about these chemotherapy related questions (42, 35, 57, and 49, respectively).
  
  
  CONCLUSIONS
  Patients preferred to receive written chemotherapy education that was reviewed with a healthcare professional and that gave more detailed information about the chemotherapeutic drugs themselves and how to prevent and manage side effects. As a result of this questionnaire, the patient education materials used at our institution will be revised to better address patients' preferences in both treatment settings.
authors.affiliation: Division of Pharmacy, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77230-1439, USA.
authors.forename: Kellie L
authors.initials: KL
authors.lastname: Jones
authors.forename: Jennifer M
authors.initials: JM
authors.lastname: Saucier
authors.forename: Charlotte C
authors.initials: CC
authors.lastname: Sun
authors.forename: Michael W
authors.initials: MW
authors.lastname: Bevers
authors.forename: Lois M
authors.initials: LM
authors.lastname: Ramondetta
authors.forename: Jubilee
authors.initials: J
authors.lastname: Brown
authors.forename: Judith A
authors.initials: JA
authors.lastname: Smith
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002173:Cancer Care Facilities / Q000458:organization & administration; D005260:Female; D005833:Genital Neoplasms, Female / Q000188:drug therapy*; D019538:Health Care Surveys; D006801:Humans; D008875:Middle Aged; D020380:Needs Assessment; D010353:Patient Education as Topic / Q000379:methods / Q000592:standards*; D017060:Patient Satisfaction
chemical_list: D000970:Antineoplastic Agents